Global Diabetic Neuropathy Market 2014-2018

2014-05-09
Price :
Published : May-2014
No. of Pages : 55

Report Description

Diabetes is usually associated with progressive damage to the nervous system, which leads to disorders collectively known as diabetic neuropathy. Diabetic neuropathy is characterized by progressive damage to the neuronal myelin sheath, which slows down nerve conduction velocity. Axonal damage associated with diabetic neuropathy decreases nerve action potential below normal physiological level, which inhibits neuronal signal transmission. About 60 to 70 percent of the diabetic population develops neuropathy, with a considerable number of cases going undiagnosed during the initial years of progression. Disease management should start with the initial diagnosis of diabetes, from educating patients to giving them regular check-ups. Diabetic neuropathy treatment involves bringing blood glucose levels within the normal range to check for further nerve damage and also additional treatment to provide symptomatic relief. Alternative therapies, which help in managing pain, such as biofeedback, meditation, acupuncture or other relaxation techniques can also be used.

TechNavio’s analysts forecast the Global Diabetic Neuropathy market will grow at a CAGR of 8.41 percent over the period 2014-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Diabetic Neuropathy market for the period 2014-2018. To calculate the market size, the report considers revenue generated through the sales of various pain management drugs administered to relieve the pain symptoms associated with diabetic neuropathy. The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Diabetic Neuropathy market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

TechNavio’s report, the Global Diabetic Neuropathy Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Diabetic Neuropathy market landscape and its growth prospects in the coming years.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Eli Lilly and Co.
  • Janssen Pharmaceuticals Inc.
  • Pfizer Inc.

Other Prominent Vendors

  • Actavis plc
  • Cephalon Inc.
  • MEDA Pharma GmbH & Co. KG

Key Market Driver

  • Increasing Global Diabetic Population.
  • For a full, detailed list, view our report.

Key Market Challenge

  • High Failure Rate in Clinical Trials.
  • For a full, detailed list, view our report.

Key Market Trend

  • Increasing R&D Activities.
  • For a full, detailed list, view our report.

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05. Introduction

06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis

07. Geographical Segmentation

08. Buying Criteria

09. Market Growth Drivers

10. Drivers and their Impact

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends

14. Trends and their Impact

15. Vendor Landscape
15.1 Competitive Scenario
15.1.1 Key News
15.1.2 Mergers and Acquisitions
15.2 Market Share Analysis 2013
15.3 Other Prominent Vendors

16. Key Vendor Analysis
16.1 Pfizer Inc.
16.1.1 Business Overview
16.1.2 Key Information
16.1.3 SWOT Analysis
16.2 Eli Lilly and Company
16.2.1 Business Overview
16.2.2 Business Segmentation
16.2.3 Key Information
16.2.4 SWOT Analysis
16.3 Janssen Pharmaceuticals Inc.
16.3.1 Business Overview
16.3.2 Key Information
16.3.3 SWOT Analysis

17. Pipeline Analysis
17.1 Phase III Analysis
17.2 Phase II Analysis
17.3 Phase I Analysis
17.4 Discontinued Projects
17.5 Projects on Hold
17.6 Promising Pipeline Molecules
17.6.1 Phase III Promising Pipeline Molecules
17.6.2 Phase II Promising Pipeline Molecules
17.7 Other First-in-class Pipeline Molecules:

18. Other Reports in this Series

List of Exhibits:

Exhibit 1: Market Research Methodology
Exhibit 2: Global Diabetic Neuropathy Market 2013-2018 (US$ billion)
Exhibit 3: Global Diabetic Neuropathy Market by Geographical Segmentation 2013
Exhibit 4: Eli Lilly and Company: Business Segmentation
Exhibit 5: Diabetic Neuropathy Pipeline Snapshot 2013
Exhibit 6: Discontinued Pipeline Molecules on the basis of MOA

Filed in: Pharmaceutical, Therapeutics
Publisher : Infiniti Research Limited
More Reports
Title Price Buy Now

Global Epinephrine Autoinjector Market 2015-2019

Epinephrine, commonly known as adrenaline, is a hormone secreted by the medulla of the adrenal gland and circulated through the bloodstream. It acts as a neurotransmitter that responds to brain signals. These signals trigger responses such as threat, excitement, danger, emotion, and stress, which stimulate the adrenal gland to secrete epinephrine in response to the changes in the body. Adrenaline prepares the body to fight against anaphylactic shock that occurs due to allergic reactions, cardiac arrest, asthma, and superficial bleeding. Chemically synthesized epinephrine is usually administered to patients suffering from the above symptoms because it stimulates the heartbeat, increases blood pressure, relaxes involuntary muscles, and constricts small blood vessels. Epinephrine is also used......
$2500

Global Hip Implant Market 2015-2019

Hip replacement is an orthopedic surgical procedure in which the damaged hip joint is replaced with an artificial joint. An artificial joint usually made from metal, ceramic, or polymeric components. The surgery is performed either by traditional technique or by minimally invasive technique. The hip replacement surgery is generally performed in patients to relieve them from arthritis pain or hip fracture. Hip replacement surgery can be total hip replacement (replacing the entire hip), partial replacement (replacing half of the joint with an artificial surface, leaving the other part in its natural state), and hip surfacing (replacing damaged bone and cartilage within the socket is removed and replaced with a metal shell). The analysts forecast the Global Hip Implant market to grow at a ......
$2500

Global Joint Reconstruction Market 2015-2019

Joint reconstruction is a procedure in which a damaged or dysfunctional joint or tissue is replaced by an artificial prosthesis. Artificial prostheses are made up of different types of materials, including metals, plastics, and ceramics. The common types of joint replacement procedures include hip and knee replacement procedures, and procedures on extremities such as ankles, wrists, shoulders, and elbows. The analysts forecast the Global Joint Reconstruction market to grow at a CAGR of 5.55 percent over the period 2014-2019. Covered in this Report The Global Joint Reconstruction market can be segmented into Knee Implants, Hip Implants, and Trauma & Extremities. The report, Global Joint Reconstruction Market 2015-2019, has been prepared based on an in-depth market analysis w......
$2500

Sterile Medical Packaging Market in the US 2015-2019

Medical products include pharmaceutical products, medical devices, surgical devices, and other healthcare-related products. Drugs/pharma products hold a major share in the Sterile Medical market. The packaging of medical products is a complex process because of their molecular and chemical structures. They need to be packaged with extremely protective and durable materials to prevent contamination. Also, the packaging materials are first sterilized before being used for packaging. The evolution of new diseases and increased health awareness have brought a transformation in the Medical Products Packaging industry. Some of the types of packaging used are bottles, vials, blisters, tubes, prefilled syringes, and prefilled inhalers, which are chosen as per the requirement of the product as well......
$2500

Global Gas Detection Equipment Market 2015-2019

Gas detectors are safety devices used to detect and monitor the concentration and quality of gas or a mixture of gases in the air. These detectors use a control system to detect harmful gases in its immediate vicinity. They are used in industrial, commercial, and other applications. These detectors constantly analyze and monitor the level of gases in power plants and provide adequate safety for working personnel in the Petroleum, Chemicals, and Power industries. The analysts forecast the Global Gas Detection Equipment market to grow at a CAGR of 4.80 percent over the period 2015-2019. Covered in this Report The report covers the present scenario and the growth prospects of the Global Gas Detection Equipment market for the period 2015-2019. The market can be segmented into two base......
$2500

Global Laboratory Information Management System (LIMS) Market 2015-2019

LIMS is the information management system specifically designed for medical and industrial-related laboratories. The solution helps scientists in tracking samples and transmitting data to professionals. LIMS offers a way of automating the laboratory, and saves time and improves the quality of data. Benefits of using LIMS are: Enhancement in efficiency of business Improvement in quality of reports Improvement in quality of data Automated quality control and customer reports Easy accessibility to data Storage of data in database TechNavio's analysts forecast the Global LIMS market to grow at a CAGR of 6.04 percent over the period 2014-2019. Covered in this Report This report covers the present scenario and the growth prospects of the Global LIMS market for the period 2......
$2500

Global Acute Coronary Syndrome (ACS) Market 2015-2019

ACS is a condition that results in sudden and reduced blood flow to the heart. ACS is a serious cardiovascular disease associated with high healthcare costs, frequent recurrences and hospitalizations, and short-term mortality. On the basis of evidence of heart muscle damage and changes in the ST-tracing of the ECG, ACS is classified into three categories: STEMI, NSTEMI, and UA. ACS is treatable if it is diagnosed quickly. The treatment options for ACS vary, depending on the signs, symptoms, and overall health condition. TechNavio's analysts forecast the Global ACS market to grow at a CAGR of 13.24 percent over the period 2014-2019. Covered in this Report The Global ACS market can be divided into three segments: STEMI, NSTEMI, and UA. This report covers the present scenario and the......
$2500

Global Gaucher Disease Market 2015-2019

Gaucher disease is a rare, inherited metabolic disorder caused by the deficiency of the enzyme glucocerebrosidase. This in turn causes the accumulation of certain detrimental lipids in the body, especially the glycolipid glucocerebroside. The lipids are accumulated mainly within the macrophages, blood cells, spleen, liver, and bone marrow. Approximately 34 genetic mutations have been identified that leads to Gaucher disease, out of which there are four most prominent mutations that lead to more than half of the Gaucher disease globally. Some people may have no symptoms of this disease, while some experience severe complications. Some of the clinical manifestations of this disease are hepatosplenomegaly, anemia, thrombocytopenia, and skeletal abnormalities. TechNavio's analysts forecast ......
$3000

Global Osteoarthritis Market 2015-2019

OA is a condition in which the cartilage, a material that cushions the joints, breaks down. This leads to stiffness, inflammation, pain, and loss of joint movement. The exact etiology of OA is not fully understood. Obesity, overuse of the joint, weak thigh muscles, aging, and genetics are some of the common risk factors of OA; OA symptoms usually develop progressively. At first, there may be stiffness that appears to be more a niggle than a medical concern. Treatment is given depending on the affected joint, including the hand, wrist, neck, back, knee, and hip, and involves medication and exercise. TechNavio's analysts forecast the Global OA market to grow at a CAGR of 8.55 percent over the period 2014-2019. Covered in this Report This report covers the present scenario and the gr......
$2500

Global Small Cell Lung Cancer Therapeutics Market 2015-2019

Cancer occurs when, after cell transformation, normal cells grow and multiply without control. Lung cancer is a common cause of mortality and morbidity in developed and developing countries. Smoking is considered to be the major cause of small cell lung cancer, though it also occurs in non-smokers. Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-15 percent of all diagnosed cases of lung cancer. Small cell lung cancer is categorized into two types: small cell carcinoma and combined small cell carcinoma. It can be further classified into two stages: limited-stage small cell lung cancer and extensive-stage small cell lung cancer. Small cell lung cancer is caused by smoking tobacco, or second ha......
$3000